| Mepha Pharma AG - Rivaroxaban-Mepha 20 mg, Hartkapseln | | 69305 | | 03 | | Rivaroxaban-Mepha 20 mg | | Hartkapseln | | B01AF01 | | Rivaroxaban | | 31.01.2025 | | |
| | Composition | | rivaroxabanum 20.0 mg, cellulosum microcristallinum, lactosum monohydricum 26.00 mg, tricalcii dicitras tetrahydricus, povidonum K 25, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 172 (rubrum), E 171, carrageenanum, kalii chloridum, aqua purificata, hypromellosum, pro capsula corresp. natrium 0.50 mg et kalium 0.14 mg. | | Packungsbestandteile | | Capsules | | | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Aqua Purificata | | | | Carmellosum Natricum Conexum | | | | Carrageenanum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | Kapselhülle | | Hypromellosum | | | | Potassium Chlorure | | | | Lactose Monohydrate | 26 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 25 | | | Silica Colloidalis Anhydrica | | | | Tricalcii Dicitras Tetrahydricus | | |
|
| |
|
